BACKGROUND: Although alcohol consumption and cigarette smoking are common behaviors in reproductive-age women, little is known about the impact of consumption patterns on ovarian reserve. Even less is known about the effects of smoking and alcohol use in reproductive-age AfricanAmerican women. OBJECTIVE: The objective of the study was to examine the impact of the patterns of alcohol intake and cigarette smoking on anti-Mü llerian hormone levels as a marker of ovarian reserve in African-American women. STUDY DESIGN: This was a cross-sectional analysis from the baseline clinical visit and data collection of the Study of Environment, Lifestyle, and Fibroids performed by the National Institute of Environmental Health Sciences. A total of 1654 volunteers, aged 23e34 years, recruited from the Detroit, MI community completed questionnaires on alcohol intake and cigarette smoking and provided serum for anti-Mü llerian hormone measurement. Multivariable linear and logistic regressions were used as appropriate to estimate the effect of a range of exposure patterns on anti-Mü llerian hormone levels while adjusting for potential confounders including age, body mass index, and hormonal contraception.
A nti-Müllerian hormone is a marker of ovarian reserve widely used in clinical practice [1] [2] [3] and is increasingly used as a tool in epidemiological studies of potential ovarian toxicants. [4] [5] [6] Despite educational campaigns on associated health risks, excessive alcohol consumption and cigarette smoking remain frequent behaviors in the United States. 7 Heavy alcohol consumption is increasingly common in reproductiveage women, 8 even those seeking conception, 9 and has been associated with decreased in vitro fertilization cycle success. 10 Cigarette smoking has established adverse effects on short-and longterm fertility [11] [12] [13] yet remains a common practice in the United States, where 1 in 5 women smoke. 14 Accordingly, whether alcohol intake and smoking behaviors influence fertility is a question of significant public health concern. 9, 10 Existing literature on alcohol intake and anti-Müllerian hormone levels is limited and suggests a possible differential impact of alcohol on anti-Müllerian hormone levels by ethnicity. Studies failed to identify a relationship with drinking and anti-Müllerian hormone levels 15 or antral follicle count in predominantly white cohorts 16 but suggest worse ovarian reserve testing among black South African women 17 and Japanese women 18 who drink. Disparate results may be attributable to racial differences in anti-Mülle-rian hormone, 19 cultural differences in alcohol consumption not reflected by the exposure variables ascertained or methodological differences in characterizing the exposure. 20 Evaluation of the impact of cigarette smoking on anti-Müllerian hormone levels has also produced discordant findings, suggesting a differential impact by age. Among perimenopausal women, current smoking was associated with lower anti-Müllerian hormone levels. 21, 22 Whereas one large study identified an inverse, dose-dependent association of smoking with antiMüllerian hormone levels, 15 other investigations failed to reproduce an association between current smoking and anti-Müllerian hormone levels. 16, 23, 24 The influence of passive smoke exposure on anti-Müllerian hormone has been sparsely studied, but one investigation demonstrated lower anti-Mülle-rian hormone levels among healthy black South African women who reported passive smoke exposure. 17 To characterize the influence of these common lifestyle exposures on ovarian reserve in the understudied AfricanAmerican population, we assessed the duration, frequency, amount, and pattern of use (eg, binge drinking, cumulative alcohol exposure, cigarettes per day, and passive smoke exposure in utero, childhood, and adulthood). We hypothesized that increased frequency and duration of alcohol consumption, cigarette smoking, and second-hand smoke exposure would be associated with lower anti-Müllerian hormone levels.
Materials and Methods

Study participants
A volunteer community sample of 1696 African-American women in the Detroit, MI area were enrolled in an ongoing prospective cohort study, the Study of Environment, Lifestyle, and Fibroids, whose primary objective is to study the incidence of fibroids in African-American women. Participants were 23e34 years of age at the time of recruitment and without a known history of uterine leiomyomata at the time of examination from November 2010 through December 2012. Recruitment and data collection procedures have been previously described. 25, 26 Women with a history of hysterectomy, autoimmune disease, or any cancer treated with radiation or chemotherapy were excluded.
Eligible participants who completed telephone interviews, all enrollment questionnaires, and a clinic visit were enrolled. Participants provided written informed consent. The study was approved by the Institutional Review Boards of the National Institute of Environmental Health Services and the Henry Ford Health System.
Exposure ascertainment
Data on patient demographics and reproductive and medical histories were self-reported. Participants provided information on drinking, smoking, and passive smoke exposure via selfadministered computer-assisted web interviewing questionnaires created specifically for use in the Study of Environment, Lifestyle, and Fibroids study. 25, 26 Comprehensive questionnaires assessed the duration, frequency, and amount of alcohol consumption, cigarette smoking, and second-hand smoke exposure both currently, defined as within the last year, and at the time of maximum consumption.
Women answered questionnaires regarding alcohol intake, including a history of regular drinking, age of initiation, number of drinks consumed in the last year and when drinking the most based on frequency of drinking and number of drinks consumed on days of consumption, frequency of binge drinking (4 or more drinks at a single occasion) in the last year and when drinking the most.
Women were categorized as ever drinkers if they reported a history of drinking at least 10 drinks in any 1 year and current drinkers if they reported drinking at least 10 drinks in the last year. Binge drinking was defined as consumption of 4 or more drinks on one occasion. 27 Consumption level was categorized as low (drinking less than once a week and never binging), moderate (drinking up to 2 days per week or binge drinking no more than monthly), and heavy (drinking more than 2 days per week or binging twice monthly or more). Cumulative alcohol exposure was denoted by level of consumption (low, moderate, high) and duration of drinking (years). In women with a history of heavy alcohol consumption, the impact of current drinking was assessed to evaluate the permanence of any association with heavy drinking and antiMüllerian hormone levels.
Smoking questionnaires assessed a history of ever smoking, age of initiation, age of cessation for past smokers, and current number of cigarettes smoked per day as well as the number of cigarettes smoked per day at the time of heaviest consumption. Regular smoking was defined as smoking at least 1 cigarette per day for more than 6 months.
Participants answered questions regarding second-hand, or passive, smoke exposure, including caregiver smoked in the home in childhood, the number of years living with smoker in childhood, in utero smoke exposure, current passive smoke exposure in the home, proportion of time in adulthood living with smoker in home, and the total number of hours per week when the participant can smell tobacco smoke.
Passive exposure to smoke in utero, childhood, and adulthood were also assessed. To capture the impact of second-hand smoke as both an isolated and cumulative smoke exposure, passive exposure was separately assessed in nonsmokers and again in all women.
Participants provided serum for antiMüllerian hormone measurement during their clinic visit. Cycle day was not included in our analysis because of the low inter-and intracycle variability with anti-Müllerian hormone. 24 Stored serum aliquots were assayed at the Clinical Laboratory Research Core within the Pathology Department at Massachusetts General Hospital (Boston, MA).
Serum anti-Müllerian hormone was measured using the pico-antiMüllerian hormone enzyme-linked immunosorbent assay (lower limit of detection 0.0016 ng/mL, 1 ng/mL ¼ 7.14 pmol/L) (Ansh Labs, Webster, TX). Samples were run at a 1:10 dilution, and then neat for the samples that were low. Anti-Müllerian hormone values that remained below the lower limit of detection (n ¼ 3) were assigned a value of 0.0011 ng/mL using an established formula. 28 The anti-Müllerian hormone enzyme-linked immunosorbent assay has intra-and interassay coefficients of variation 6.9% and 6.5%, respectively.
Statistical analysis
The relationship among alcohol consumption variables and anti-Müllerian hormone levels in the cohort were assessed using multivariable-adjusted linear and logistic regression models. Anti-Müllerian hormone levels were log transformed to account for nonnormal distribution, and all models were adjusted for age, body mass index, and current hormonal contraception, variables that were previously shown to be significantly associated with anti-Müllerian hormone levels in this cohort. 29 Recognizing the nonlinear association between age and ovarian reserve, main effects models included both an age and an age quadratic term. Considering the natural, age-related decline in antiMüllerian hormone levels occurring at 25 years, 30, 31 sensitivity analyses were performed to examine interactions between age and exposure variables. This
Original Research GYNECOLOGY ajog.org allowed for an age-related decline in anti-Müllerian hormone to differ between exposed compared with unexposed participants.
Because nondrinkers may represent a highly selected group in the United States, as suggested by a J-shaped distribution for the effects of alcohol on adverse health outcomes, 32 a separate analysis was restricted to current drinkers, as has been done in previous investigations. 33 Linear regression models with log anti-Müllerian hormone as the dependent variable generated adjusted estimates of b associated with each exposure of interest. Percentage differences and 95% confidence intervals in serum antiMüllerian hormone between exposure groups were calculated from the bs as follows ([exp(b) e 1] * 100) and presented with corresponding 95% confidence intervals or P values. Significant associations in linear regression models were further explored in multivariableadjusted logistic regression models to assess the odds of diminished ovarian reserve (DOR), defined as anti-Müllerian hormone <1, and confidence intervals.
All analyses were carried out using Statistical Analysis Software version 9.4 (SAS Institute, Cary, NC). Continuous variables are presented as means or medians with (SD or interquartile ranges). Potential confounders were assessed using simple linear regression and were considered for addition to the final model if they changed the risk ratio by more than 10%. 34 Statistical significance was assumed for P< .05.
Results
A total of 1654 reproductive-aged African-American women submitted comprehensive questionnaires on alcohol consumption and provided serum for anti-Müllerian hormone measurement. The mean age of participants was 29 years, median serum antiMüllerian hormone concentration was 3.2 ng/mL, and most women were obese with a median body mass index of 32 kg/ m 2 . Additional demographic details are presented in Table 1 and median antiMüllerian hormone levels by age are presented in Figure 1 .
Alcohol consumption
The majority (74%) of participants reported current (71%) or former (3%) drinking. The average age of drinking initiation was 20 (AE3.3) years and most drinkers (84%) reported their heaviest ajog.org GYNECOLOGY Original Research consumption occurred after their teen years. Of all participants, 25% reported weekly or more frequent drinking and 54% reported binge drinking in the last year. When the analysis was restricted to women who currently drink (n ¼ 1168), most (74%) reported binge drinking in the last year, and of these, 26% reported binging multiple times per month.
When drinkers and nondrinkers (reference category) were compared, there were no significant associations between anti-Müllerian hormone levels and any of the numerous drinking behaviors assessed, including past and current behaviors (Table 2 ). This included no association of current alcohol intake with anti-Müllerian hormone levels among women with a history of prior heavy alcohol intake. However, those who binge drank twice a week or more had a 21% lower antiMüllerian hormone level compared with those who never drink (95% confidence interval, e41 to 7) ( Table 2) .
When analyses were limited to current drinkers, the influence of high frequency binging on anti-Müllerian hormone levels was stronger. Women who reported binge drinking twice weekly or more frequently had 26% lower antiMüllerian hormone levels compared with current drinkers who never binged (95% confidence interval, e44, to e2; P ¼.036, Figure 2 ). This did not translate to increased odds of diminished ovarian reserve (odds ratio, 0.85, 95% confidence interval, 0.5e2.7, P ¼ .39). Figure 1 demonstrates associations between binge drinking patterns and 
Median AMH by age
Median AMH (nanograms per milliliter) by age (years) (n ¼ 1654).
AMH, anti-Mü llerian hormone.
Hawkins Bressler et al. Alcohol, tobacco, and AMH levels. Am J Obstet Gynecol 2016.
Original Research GYNECOLOGY ajog.org anti-Müllerian hormone levels among current drinkers. There was no association with teenage drinking, frequency or duration of drinking, current heavy drinking, or ever binging (results not presented).
Cigarette smoking
Most women (73%) never smoked regularly, 7% formerly smoked, and 19% were current smokers. Among current smokers, only 4% smoked a pack or more a day. The average age of smoking initiation was 18 (AE4) years, cessation was 25 (AE4) years, and the average duration of smoking was 6 (AE5) years, none of which were associated with antiMüllerian hormone levels (all P > .05, Table 3 ).
Second-hand smoke exposure
When assessing the influence of environmental smoke exposure in neversmokers, main results demonstrate no association between anti-Müllerian hormone levels and in utero, childhood, and current second-hand exposure (all P > .05, Table 3 ). There was no significant association for high passive smoke exposure as measured by the number of hours per day smelling smoke (31% lower for women with 10 or more hours compared with those with none, 95% confidence interval, e60 to 20). Relationships remained nonsignificant when the analysis sample was expanded to include smokers rather than being limited to nonsmokers (results not presented).
Age sensitivity analyses
Sensitivity analyses showed no significant exposure effects on the age-related rate of anti-Müllerian hormone decline for drinking-and smoking-related variables (data not presented).
Comment
This work assessed the influence of patterns of alcohol consumption, cigarette smoking, and passive smoke exposure on ovarian reserve as measured by antiMüllerian hormone levels 35 in reproductive-aged African-American women. Major findings include an inverse association with frequent binging and anti-Müllerian hormone levels in current drinkers.
To our knowledge this is the first study to evaluate the impact of alcohol consumption and cigarette smoking on anti-Müllerian hormone levels in this demographic and the first in any population to evaluate how patterns of exposure to alcohol (eg, binge drinking) and cigarette smoke (eg, passive childhood and in utero smoke exposure) influence anti-Müllerian hormone. The comprehensive questionnaire permitted a detailed assessment of current and former consumption patterns.
Findings imply that current, frequent binge drinking may have an adverse impact on anti-Müllerian hormone levels but that less heavy drinking, cigarette smoking, and passive smoke exposure do not influence anti-Müllerian hormone levels in a cohort of healthy, young African-American women.
Although the impact of binge drinking on anti-Müllerian hormone has not been previously assessed, our finding of lower anti-Müllerian hormone levels in frequent binge drinkers is consistent with a Japanese study demonstrating worse ovarian function in current heavy drinkers. 18 Loss of significance when comparing frequent binge drinkers to never-drinkers may reflect an unhealthy nondrinker effect. 33, 36 On the other hand, the number of women with heavy exposure was small, and there was no suggestion of a dose response, so the association may be a chance finding. However, there is a biological plausibility for the detrimental effects of binging. Acute alcohol ingestion has been associated with increased estradiol levels 37 and gonadotropins are 
FIGURE 2
Binge drinking pattern and AMH levels among 1168 current drinkers Frequent binge was binge drinking at least twice weekly vs never-bingers. Weekly binge was binge drinking at least once a week vs neverbingers. Biweekly binge was binge drinking at least every 2 weeks vs never-bingers. Monthly binge was binge drinking monthly or less vs never-bingers. 38 such that alcoholinduced alterations in hepatic catabolism of estradiol or gonadotropins may have an impact on the hypothalamicpituitary axis signaling.
Alternatively, repeated large-volume alcohol exposures may overwhelm the protective mechanisms of the granulosa complex. 39 In our study population, anti-Müllerian hormone levels began declining at 25 years of age, in keeping with previous studies, such that binge drinking in the late 20s might accelerate the natural decline of anti-Müllerian hormone. [29] [30] [31] 40 Considering that binge drinking is common in young women in the United States, 7 this finding is important to examine further.
The null associations between a wide range of alcohol drinking behaviors and anti-Müllerian hormone levels are in keeping with prior studies that failed to identify associations of anti-Müllerian hormone levels with ever-drinking, daily consumption, and number of drinks per day in white women. 15, 16 Null associations between alcohol consumption patterns and anti-Müllerian hormone levels may reflect the durability of the protective mechanisms of the granulosa cells in reproductive-age women. 39 It is plausible that current heavy, alcohol consumption has negative impacts on fertility and in vitro fertilization outcomes 10 but that this impact is temporary in the absence of repeated largevolume exposures sufficient to cause permanent liver damage. Our finding that prior heavy alcohol intake was not associated with anti-Müllerian hormone levels but that current frequent binge drinking is associated with lower antiMüllerian hormone levels supports this assertion, although future investigation assessing anti-Müllerian hormone levels by current drinking status among women with a history of frequent binge drinking is merited.
With regard to smoking, our results provide a detailed assessment of the impact of active and passive smoking in young women but are limited by small numbers of heavy smokers. Findings of the present work are consistent with studies that failed to identify a relationship with current smoking and anti- 41 a recent genomic study identified an increased rate of follicular decline in middle-aged smokers and used this finding to argue that an increased rate of follicular decline because of smoking might be evident only at midlife. 22 Considering the wellestablished relationship of smoking on premature ovarian aging, [42] [43] [44] it is plausible that smoking is associated with ovarian aging but that this is either not evident in younger women based on anti-Müllerian hormone or was not detected because of a low frequency of heavy smoking in our cohort.
Strengths of this study included a novel investigation of the impact of alcohol intake and cigarette smoking on anti-Müllerian hormone levels in healthy, reproductive-aged African-American women. Comprehensive questionnaires permitted a detailed characterization of exposure. Prevalence of lifestyle behaviors in our population was comparable with national estimates including the prevalence of current drinking (71% vs. 80%, respectively), and current smoking (9% vs 18%), 14 suggesting external validity. A large sample size further allows for external validity within the reproductive-aged female AfricanAmerican population.
Limitations included a cross-sectional analysis and the use of a single ovarian reserve marker. However, anti-Müllerian hormone was measured using a sensitive and reliable (<7% coefficient of variation) assay, and studies show high correlation between antral follicle counts and anti-Müllerian hormone. 45 The Study of Environment, Lifestyle, and Fibroids was not initially powered to detect associations between alcohol intake and anti-Müllerian hormone. Consequently, we cannot be certain whether our null associations are TABLE 3 Associations of cigarette smoking and second-hand cigarette smoke exposure on anti-Mü llerian hormone levels among 1654 reproductive-aged African American women (continued) attributable to an actual lack of association or to inadequate statistical power.
An entirely African-American study population preserves internal validity and fills a gap in the anti-Müllerian hormone literature that predominantly involves white women but may limit generalization to populations with other demographic compositions. Our selfreported data introduce the possibility of underreporting (social desirability bias), although this was reduced by the use of a self-administered computerassisted web interviewing questionnaire. 46 In addition, self-reported smoking data have been validated previously with serum cotinine measures for both African-Americans and whites. 47, 48 Alcohol intake was collected with both the computer-assisted web interview developed for the Study of Environment, Lifestyle, and Fibroids and the webbased Block 2005 Food Frequency Questionnaire, 49 and these surveys were completed at different times for most women. For analysis, data from the computer-assisted web interviewing was used because the alcohol questions were more extensive and response categories allowed for reporting of higher alcohol intake. Still, the correlation between the two surveys for the number of drinks per month during the past year was 0.75, indicating good reliability.
This study found that anti-Müllerian hormone levels were 26% lower in women who engage in current, frequent binge drinking, even after adjustment for age, body mass index, and hormone use. Other patterns of current and past alcohol consumption, cigarette smoking, and smoke exposure were not associated with anti-Müllerian hormone. Remaining gaps in knowledge include an assessment of whether threshold levels of exposure exist above which ovarian protective mechanisms are overwhelmed and whether the impairment in ovarian reserve as a result of repeated binge drinking represents a temporary insult, as our results suggest, or rather a permanent reduction in ovarian reserve.
Reproduction of results in prospective investigations would confirm the findings presented herein. The study of longitudinal changes in anti-Müllerian hormone as a result of lifestyle factors would inform the transience or permanence of such associations over time and better characterize the impact of these common lifestyle behaviors on ovarian reserve. n
